Medical Updates: Remedy Choices for COVID-19

Many sufferers impacted by the COVID-19 virus expertise gentle sickness and get well at residence after a number of days. A few of the signs for these sufferers embody fever, chills, cough, shortness of breath, fatigue, muscle or physique aches, complications, sore throat, and diarrhea. These people can normally deal with their signs with OTC drugs corresponding to acetaminophen or ibuprofen.¹

For sufferers which will have comorbidities or expertise extra extreme COVID-19 illness, there are different remedy choices obtainable that may assist not solely enhance the signs, but additionally cut back the danger of hospitalization. These drugs are efficient particularly if they’re prescribed and began inside 5 to 7 days of the signs’ look. That is particularly vital for older adults (>50 years), those that are unvaccinated or not updated with their vaccinations, and people with sure medical circumstances, corresponding to lung illness, coronary heart illness, or a weakened immune system.²

The FDA has authorized and licensed a number of antiviral drugs that can be utilized to deal with gentle to average COVID-19 signs in these which are very sick or vulnerable to extra extreme sickness, together with antiviral remedy drugs. Antiviral brokers goal particular components of the virus to cease it from rising and multiplying within the physique. These choices embody nirmatrelvir and ritonavir (Paxlovid; Pfizer), remdesivir (Veklury; Gilead), and molnupiravir (Lagevrio; Merck).²

Mixture nirmatrelvir and ritonavir is permitted for adults and kids 12 years and older and must be began as quickly as potential inside 5 days of preliminary signs. This treatment is available in a 300mg/100mg dose pack and 150mg/100mg dose pack for sufferers’ use. You will need to educate sufferers on potential opposed results, together with liver issues, allergic reactions, and drug-drug interactions.

Remdesivir is one other antiviral agent that can be utilized in adults and kids. This treatment is to be began as quickly as potential inside 7 days of symptom emergence. Remdesivir is simply obtainable intravenously (IV) in a well being care facility and is a nucleotide prodrug of an adenosine analog, which binds to the viral RNA-dependent RNA polymerase and inhibits the replication of the RNA transcription. The IV formulation is authorized by the FDA for the remedy of COVID-19 sufferers aged ≥28 days and weighing ≥3 kg. In these hospitalized with COVID-19, remedy with remdesivir ought to proceed for five days or till discharge.³

An alternative choice is molnupiravir. That is one other antiviral agent for adults, to be began inside 5 days of symptom onset. This treatment may be taken at residence by mouth, and the 4 capsules must be taken each 12 hours for five days. Sufferers can take this treatment with or with out meals.⁴

As of December 2022, almost 6 million People have taken nirmatrelvir/ritonavir.⁵ Up to now, remdesivir has been made obtainable to greater than 10 million sufferers world wide, together with 7 million in 127 international locations by means of the producer Gilead.⁶ As we transfer ahead with COVID-19, many of those drugs have gotten extra obtainable and inexpensive for the general public.

It’s important for the sufferers taking any of the talked about remedy choices to be educated in regards to the drugs, know the right way to take them, and for the way lengthy. Sufferers ought to usually be instructed to report signs of illness, corresponding to fever, chills, cough, shortness of breath, fatigue, muscle and physique ache, and complications to their well being care suppliers as quickly as potential, to allow them to be began on probably the most acceptable COVID-19 remedy as early as potential for higher outcomes. With wider testing obtainable, diagnosing COVID-19 has change into simpler and lots of sufferers now have entry to vital remedy choices in opposition to the COVID-19 virus.

References

1. Signs of COVID-19. CDC. Up to date October 26, 2022. Accessed November 29, 2023. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/signs.html

2. COVID-19 Remedies and Medicines. CDC. Up to date November 17, 2023. Accessed November 29, 2023. https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html

3. Remdesivir. NIH COVID-19 Remedy Pointers. Up to date July 21, 2023. Accessed November 29, 2023. https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/remdesivir/

4. Truth Sheet for Sufferers and Caregivers: EUA of Lagevrio (molnupiravir) capsules for Coronavirus Illness 2019 (COVID-19). FDA. Revised October 2023. Accessed November 29, 2023. https://www.fda.gov/media/155055/obtain

5. Recht H. COVID-19 remedy Paxlovid has been free up to now. Subsequent yr, sticker shock awaits. PBS. December 18, 2022. Accessed November 29, 2023. https://www.pbs.org/newshour/well being/covid-19-treatment-paxlovid-has-been-free-so-far-next-year-sticker-shock-awaits

6. FDA Approves Veklury (Remdesivir) for the Remedy of Non-Hospitalized Sufferers at Excessive Threat for COVID-19 Illness Development. Gilead. January 21, 2022. Accessed November 29, 2023. https://www.gilead.com/news-and-press/press-room/press-releases/2022/1/fda-approves-veklury-remdesivir-for-the-treatment-of-nonhospitalized-patients-at-high-risk-for-covid19-disease-progression